Cargando…

High-density lipoprotein of patients with Type 2 Diabetes Mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate

BACKGROUND: Dysfunctional high-density lipoprotein (HDL) may have pro-inflammatory effects on the endothelial cells,which causes atherosclerosis in type 2 diabetes mellitus (T2DM). HDL is a major carrier of sphingosine-1-phosphate (S1P) in plasma while S1P exhibits multiple biological activities. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Xunliang, Peng, Hui, Liu, Donghui, Ji, Liang, Niu, Chenguang, Ren, Jun, Pan, Bing, Hu, Jianying, Zheng, Lemin, Huang, Yining
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599898/ https://www.ncbi.nlm.nih.gov/pubmed/23360427 http://dx.doi.org/10.1186/1475-2840-12-27

Ejemplares similares

The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus
por: Tong, Xunliang, et al.
Publicado: (2014)

HDL-bound sphingosine 1-phosphate restrains lymphopoiesis and neuroinflammation
por: Blaho, Victoria A., et al.
Publicado: (2015)

Cyclooxgenase-2 Inhibiting Perfluoropoly (Ethylene Glycol) Ether Theranostic Nanoemulsions—In Vitro Study
por: Patel, Sravan Kumar, et al.
Publicado: (2013)

Novel Allelic Variants in the Canine Cyclooxgenase-2 (Cox-2) Promoter Are Associated with Renal Dysplasia in Dogs
por: Whiteley, Mary H., et al.
Publicado: (2011)

Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication
por: Chen, Jennifer S., et al.
Publicado: (2020)

Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
por: Winkler, Martin Sebastian, et al.
Publicado: (2019)

Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases
por: Diarte-Añazco, Elena M. G., et al.
Publicado: (2019)

Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes
por: LV, PU, et al.
Publicado: (2016)

Expression of Concern: Novel Allelic Variants in the Canine Cyclooxgenase-2 (Cox-2) Promoter Are Associated with Renal Dysplasia in Dogs
Publicado: (2012)

Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL
por: Yalcinkaya, Mustafa, et al.
Publicado: (2020)

Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate
por: Wang, Xi, et al.
Publicado: (2017)

Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate
por: Kobayashi, Tamaki, et al.
Publicado: (2021)

High-density lipoprotein induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through sphingosine kinase-2
por: Xiong, Sheng-Lin, et al.
Publicado: (2014)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Sphingosine-1-Phosphate Receptor 3 Mediates Sphingosine-1-Phosphate Induced Release of Weibel-Palade Bodies from Endothelial Cells
por: van Hooren, Kathinka W. E. M., et al.
Publicado: (2014)

Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2
por: Chumanevich, Alena, et al.
Publicado: (2016)

Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptor 3 Are Functionally Upregulated on Astrocytes under Pro-Inflammatory Conditions
por: Fischer, Iris, et al.
Publicado: (2011)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023)

Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
por: Ono, Yoshikazu, et al.
Publicado: (2013)

Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes
por: Guitton, Jeanne, et al.
Publicado: (2020)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

The Apolipoprotein M–Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis
por: Arkensteijn, Bas W. C., et al.
Publicado: (2013)

Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment
por: Brulhart‐Meynet, Marie‐Claude, et al.
Publicado: (2021)

Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus
por: Kurano, Makoto, et al.
Publicado: (2022)

Divergent roles of prostacyclin and PGE(2) in human tendinopathy
por: Bergqvist, Filip, et al.
Publicado: (2019)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
por: Ceccom, Johnatan, et al.
Publicado: (2014)

Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway
por: Gu, Yapeng, et al.
Publicado: (2011)

Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism
por: Kwong, Eric, et al.
Publicado: (2015)

MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells
por: Kobayashi, Naoki, et al.
Publicado: (2018)

Sphingosine-1-Phosphate Receptor 2 Regulates Proinflammatory Cytokine Production and Osteoclastogenesis
por: Yu, Hong
Publicado: (2016)

Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
por: Blankenbach, Kira V., et al.
Publicado: (2016)

Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment
por: Wang, Wei, et al.
Publicado: (2020)

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts
por: Keller, Johannes, et al.
Publicado: (2014)

High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway
por: Frias, Miguel A., et al.
Publicado: (2012)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
por: Ito, Fumiaki, et al.
Publicado: (2020)

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate
por: Mishima, Yuko, et al.
Publicado: (2018)

Irisin Is Target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated Signaling in Skeletal Muscle Cells
por: Pierucci, Federica, et al.
Publicado: (2023)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
por: Cho, Kyung-Hyun
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4mup2j5743beidd9nmjo2kq8s